|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 19, 308-313, Copyright © 1980 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
NL Burstein
Benzalkonium chloride (BAC) and chlorhexidine digluconate (CDG) were applied to rabbit and cat corneal epithelium in clinically used concentrations. Corneas were fixed 1/2 hr later and examined by scanning electron microscopy (SEM). BAC was found to produce a progressive increase in damage at concentrations between 0.001% and 0.01% as determined by SEM. CGD produced less damage than BAC at any concentration. Cats lacrimated copiously and blinked frequently after instillation of drops; rabbits did not. No significant difference was found between the two species, however, in their response to the preservative agents tested. It is presumed that binding of these surface active agents occurs almost immediately and is unaffected by tear film dilution. Studies measuring permeability increase in the human eye after preservative use are required to allow clinical interpretation of the data presented here.
This article has been cited by other articles:
![]() |
C. Xiong, D. Chen, J. Liu, B. Liu, N. Li, Y. Zhou, X. Liang, P. Ma, C. Ye, J. Ge, et al. A Rabbit Dry Eye Model Induced by Topical Medication of a Preservative Benzalkonium Chloride Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1850 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pauly, F. Brignole-Baudouin, A. Labbe, H. Liang, J.-M. Warnet, and C. Baudouin New Tools for the Evaluation of Toxic Ocular Surface Changes in the Rat Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5473 - 5483. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Pisella, P Pouliquen, and C Baudouin Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication Br. J. Ophthalmol., April 1, 2002; 86(4): 418 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Geerling, J. T. Daniels, J. K. G. Dart, I. A. Cree, and P. T. Khaw Toxicity of Natural Tear Substitutes in a Fully Defined Culture Model of Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 948 - 956. [Abstract] [Full Text] |
||||
![]() |
K. Miyake, I. Ota, N. Ibaraki, J. Akura, S. Ichihashi, Y. Shibuya, K. Maekubo, and S. Miyake Enhanced Disruption of the Blood-Aqueous Barrier and the Incidence of Angiographic Cystoid Macular Edema by Topical Timolol and Its Preservative in Early Postoperative Pseudophakia Arch Ophthalmol, March 1, 2001; 119(3): 387 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A Niszl and M. B Markus Anti-Acanthamoeba activity of contact lens solutions Br. J. Ophthalmol., September 1, 1998; 82(9): 1033 - 1038. [Abstract] [Full Text] |
||||
![]() |
C. Baudouin and C. de Lunardo Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers Br. J. Ophthalmol., January 1, 1998; 82(1): 39 - 42. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |